Credit Suisse analyst Trung Huynh maintained a Hold rating on Roche Holding AG (RHHVF) yesterday and set a price target of CHF350.00. The company’s shares closed last Thursday at $352.71.
According to TipRanks.com, Huynh is ranked #1134 out of 6704 analysts.
Currently, the analyst consensus on Roche Holding AG is a Strong Buy with an average price target of $402.67.
See today’s analyst top recommended stocks >>
The company has a one-year high of $399.00 and a one-year low of $265.65. Currently, Roche Holding AG has an average volume of 15.3K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
